From the July 2019 issue of Duke Medicine’s Health News (HN)
A Fibromyalgia Test May Be on the Way
This oft-misdiagnosed disease has a distinctive metabolic signature, a new study suggests.
You are trying to access subscriber-only content.
If you are a subscriber, .
If you are not a subscriber, or are only subscribed to the print edition, click here to subscribe now. Digital subscribers have unlimited access to our magazine articles and more!
Fibromyalgia is the most common cause of chronic widespread pain in the United States, affecting 2 to 8 percent of the population, but it has no diagnostic test. In addition to pain, fatigue, muscle spasms, weakness, skin tingling, bowel disturbances, and cognitive dysfunction, people with the disease face the difficulty of struggling with a condition […]